Herpes simplex virus type-1(HSV-1) oncolytic and highly fusogenic mutants carrying the NV1020 genomic deletion effectively inhibit primary and metastatic tumors in mice

Herpes simplex virus type-1(HSV-1) oncolytic and highly fusogenic mutants carrying the NV1020 genomic deletion effectively inhibit primary and metastatic tumors in mice

<p>Abstract</p> <p>Background</p> <p>The NV1020 oncolytic herpes simplex virus type-1 has shown significant promise for the treatment of many different types of tumors in experimental animal models and human trials. Previously, we described the construction and use of t...

Full description

Bibliographic Details
Main Authors: David Andrew T, Baghian Abolghasem, Chouljenko Vladimir N, Israyelyan Anna, Kearney Michael T, Kousoulas Konstantin G
Format: Article
Language:English
Published: BMC 2008-06-01
Series:Virology Journal
Online Access:http://www.virologyj.com/content/5/1/68

Internet

http://www.virologyj.com/content/5/1/68

Similar Items